What does the Oscar Health Q2 2025 preliminary earnings really mean?
Ahead of its official August 6 release, Oscar Health shared a $228 million net loss forecast, rising ACA risk scores, and an early move to revise 2026 pricing.
The preliminary Q2 2025 financial results press release outlines the reasoning behind these early disclosures, offering insight into a shifting insurance market and how Oscar is preparing for it.
In this post, you’ll get a breakdown of the early financial indicators, the strategic changes underway, and what this means for Oscar’s outlook through 2025 and into 2026.
Key Takeaways
- Oscar Health forecasts a $228M net loss for Q2 2025
- ACA market risk scores are rising, suggesting higher enrollee morbidity
- Medical Loss Ratio projected to increase to 86–87%
- Company is proactively revising 2026 pricing based on new risk data
- Adjusted EBITDA loss is $120M better than operating loss
- Strategic cost controls and investment income are helping stabilize performance
Table of Contents
What Are ACA Risk Adjustment Reports and How Do They Affect Oscar Health?
Risk Adjustment Reports—used by CMS and independent analysts, evaluate the health status of insurance enrollees and redistribute money between plans to ensure fairness. Insurers with healthier members contribute to the pool, while those with higher-risk populations receive payments to offset costs.
Wakely’s analysis of Oscar Health’s Q2 Risk Adjustment Reports showed higher-than-expected market morbidity, meaning sicker enrollees across the ACA Marketplace. As a result, Oscar is adjusting expectations for revenue, cost exposure, and pricing strategy—starting with 2026.
Why Is Oscar Health Revising Its 2025 Earnings Guidance?
Oscar Health revised its full-year 2025 guidance to reflect current market pressures. Here’s the updated outlook
| Metric | Low Estimate | High Estimate |
|---|---|---|
| Total Revenue | $12.0 billion | $12.2 billion |
| Medical Loss Ratio (MLR) | 86.0% | 87.0% |
| SG&A Expense Ratio | 17.1% | 17.6% |
| Loss from Operations | ($300 million) | ($200 million) |
- Medical Loss Ratio (MLR): The percentage of premiums spent on member care. A higher MLR benefits patients but reduces profitability.
- SG&A Expense Ratio: A measure of how efficiently the company manages operating expenses relative to revenue.
- Loss from Operations: Core business losses before factoring in taxes, interest, or depreciation.
While losses remain steep, Oscar expects its adjusted EBITDA to come in $120 million better than its operating loss, driven by cost controls and investment income.
What’s Behind Oscar Health’s 2026 Rate Filing Revisions?
Oscar Health is proactively planning for 2026 by resubmitting rate filings in states covering 98% of its current membership. Why? The latest ACA risk data shows higher market morbidity, signaling that insured populations are sicker and more expensive than previously expected.
To stay sustainable, Oscar is adjusting pricing to match that risk. CEO Mark Bertolini emphasized that pricing discipline is critical for the company’s long-term strategy and financial resilience.
How Are Other Insurers Responding to ACA Risk and Pricing Pressures?
Oscar Health isn’t alone in revising rates and guidance—many ACA insurers are feeling the heat. Across the 2026 rate filing season, most carriers are responding to similar challenges: higher market morbidity, elevated service utilization, and regulatory uncertainty.
Recent analyses from KFF and Peterson-KFF Health System Tracker show that the median requested premium increase across 105 ACA plans is around 15%, with more than a quarter seeking hikes of 20% or more. This points to a broader recalibration across the individual market.
Large players, such as Centene and Elevance Health, have pulled back or lowered their guidance, citing similar enrollment and cost trends. In Texas and Illinois, Blue Cross Blue Shield plans are proposing double-digit increases, with some filings exceeding 27%.
Even UnitedHealth Group has flagged regulatory uncertainty and changing subsidy rules as reasons for recalibrating its ACA pricing models ahead of 2026. This industry-wide response underscores that Oscar’s early rate filings are not an outlier—they’re part of a strategic trend.
In context, Oscar’s proactive adjustments reflect a larger shift in how insurers are navigating risk and pricing discipline in a post-COVID, post-subsidy-boost ACA environment.
Want to see how this trend is playing out nationwide? Explore these related stories:
- U.S. health insurers seek largest jump in Obamacare premiums since 2018 – Reuters
- Obamacare Insurers Seek Double-Digit Premium Hikes – Wall Street Journal
- Oscar Health is Latest Insurer to Cut Earnings Guidance – Becker’s Payer Issues
Why Is Oscar Health’s Medical Loss Ratio Rising in 2025?
Oscar Health now expects its Medical Loss Ratio (MLR) for 2025 to fall between 86.0% and 87.0%, up from earlier forecasts. This spike reflects a combination of elevated service utilization, only modest improvement in cost trends since Q1, and worsening overall market health.
Even with better cost control in the back half of the year, these headwinds could continue to weigh on earnings.
The video offers a quick breakdown of Oscar Health’s preliminary Q2 2025 results. It covers the projected $228 million net loss and the jump in Medical Loss Ratio (MLR). The host explains how rising ACA risk scores influenced the early earnings release and highlights Oscar’s proactive 2026 rate filing strategy.
What’s Changing in the ACA Marketplace and How It Impacts Oscar Health?
The ACA individual market has always been a bit of a wild ride. In theory, it offers affordable coverage and a broad network of plans. But in practice, it’s a complex balancing act between pricing, enrollment behavior, and risk adjustment mechanics.
Right now, that balance is tilting. As more people with chronic conditions or higher health needs enroll, insurers like Oscar are seeing rising claim volumes. At the same time, pricing for 2025 may have underestimated this shift.
Oscar’s preliminary results reflect that pivot. And instead of riding it out, they’re taking a clear stance: update rates, adjust strategy, and refocus on the fundamentals.
The ACA isn’t broken, but it’s evolving. And Oscar Health is trying to stay ahead of that curve before it turns into a cliff.
What Does Adjusted EBITDA Reveal About Oscar Health’s Core Business?
While headlines tend to focus on net loss or operating loss, Adjusted EBITDA gives us a different angle. For Q2 2025, Oscar is projecting an Adjusted EBITDA loss that is roughly $120 million less than its operating loss.
So what exactly is Adjusted EBITDA?
Adjusted EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, adjusted for non-recurring or non-cash expenses like stock-based compensation.
This metric strips out the accounting noise to show how well the core business is performing. For Oscar, it suggests that despite a substantial operating loss, the underlying operations may be stronger than they appear at first glance.
Still, it’s not a profitability signal yet. But it is a sign that Oscar is narrowing its losses and staying disciplined in how it spends.
They’ve even noted that investment income and cost controls are helping soften the blow. And in this market, flat is the new up.
Should You Be Concerned About Oscar Health Q2 2025 Preliminary Earnings Results?
It depends on your view of the long game.
Yes, Oscar Health is forecasting a substantial Q2 2025 loss, but they’re also being transparent about why—and what they’re doing to course-correct. If anything, this preannouncement signals confidence in their ability to manage expectations and steer toward stability.
Here’s where it gets nuanced:
- Marketplace risk scores are rising, but that’s not exclusive to Oscar.
- They’re already updating 2026 pricing, which shows strategic foresight.
- Adjusted EBITDA is improving, even if losses remain.
But it’s not all sunshine. The ACA market is tough right now. Margins are tight. Risk adjustment is unpredictable. And Oscar is still not profitable.
Yet for long-term investors who understand healthcare cycles, these preliminary results could signal the start of a stronger strategic phase.
When Will Oscar Health Release Its Full Q2 2025 Earnings?
Mark your calendar: Wednesday, August 6, 2025, is when the full story drops. Oscar will release its second quarter 2025 earnings before the market opens, followed by a conference call at 8:00 AM ET.
That call should bring clarity around:
- The final numbers (not just estimates)
- Updated commentary on pricing and utilization
- Progress on cost-cutting and platform growth
- Any shifts in +Oscar or tech stack monetization
Until then, this early peek shows Oscar being honest about headwinds—and ready to adjust.
What is the main takeaway from Oscar Health’s Q2 2025 earnings preview?
Oscar Health is forecasting a $228 million net loss and expects its Medical Loss Ratio (MLR) to rise to 86–87% for 2025. These projections reflect increased market morbidity and higher-than-expected utilization, prompting the company to revise its 2026 pricing and overall financial guidance.
Why did Oscar Health release its earnings preview early?
Oscar Health released its preliminary Q2 2025 results ahead of schedule in response to updated risk adjustment data from Wakely. The data revealed rising ACA risk scores, leading the company to revise financial expectations and act early on 2026 rate filings in most of its markets.
What does a higher Medical Loss Ratio (MLR) mean for Oscar?
A higher MLR means a larger percentage of premiums are going toward paying members’ medical claims. While it shows the company is providing care, it also signals tighter margins and financial strain—especially when combined with elevated service utilization and ACA marketplace changes.
How is Oscar Health adjusting for 2026?
Oscar plans to resubmit rate filings in states covering 98% of its current membership. These filings will reflect the higher morbidity discovered in ACA markets and are part of the company’s broader effort to ensure financial sustainability and maintain pricing discipline moving forward.
When will Oscar Health release full Q2 2025 earnings?
Oscar Health will officially report its full Q2 2025 financial results on Wednesday, August 6, 2025, before the market opens. A live conference call will follow at 8:00 AM ET, providing more detail on utilization trends, pricing updates, and strategic outlooks.
Oscar Health’s Q2 2025 Preview Isn’t Just About the Numbers
Oscar Health’s Q2 2025 earnings preview reveals more than just a $228 million loss—it highlights a shifting ACA landscape, rising medical costs, and the company’s proactive steps to stay ahead. From elevated MLR to revised 2026 rate filings, Oscar is signaling strategic discipline in the face of mounting headwinds.
By analyzing the early data, risk adjustment impacts, and forward-looking actions, you now have a clearer picture of what’s driving these changes and what they mean for the months ahead.
Whether you’re a healthcare investor, operator, or curious observer, you’ve just gained the insight to interpret Oscar’s financial playbook before the full earnings drop. Stay tuned, there’s more to come when the full report lands on August 6.
Coming Soon: Full Oscar Health Q2 2025 Earnings Breakdown
Want to know how the actual results compare to this preview?
We’ll be diving into the official Oscar Health Q2 2025 earnings right after they’re released on August 6—covering final numbers, CEO insights, and what it all means for the rest of 2025.
Bookmark this site and check back soon for the full breakdown.
Written by Bryan Smith, creator of Straight From the Call.
I break down earnings calls so you don’t have to. Clear takeaways, no fluff — just the stuff investors care about.
This post is for informational and educational purposes only. It does not constitute financial, investment, or legal advice. Always do your own research or consult a licensed professional before making financial decisions.